Aripiprazole 5 mg tablets are a dosage form of aripiprazole, an atypical antipsychotic medication used to treat conditions such as schizophrenia, bipolar disorder, and major depressive disorder [1].
What is Aripiprazole 5 mg used for?
Aripiprazole 5 mg tablets are prescribed for the treatment of schizophrenia in adults and adolescents 13 years and older [2]. This dosage is also indicated for the acute and adjunctive treatment of manic or mixed episodes associated with bipolar I disorder in adults and children 10 years and older [2]. Additionally, it can be used as an adjunctive treatment for major depressive disorder in adults [2].
How does Aripiprazole work?
Aripiprazole is believed to exert its therapeutic effects by acting as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors, and as an antagonist at serotonin 5-HT2A receptors [2]. This mechanism helps to modulate the activity of dopamine and serotonin in the brain, which are neurotransmitters implicated in various mental health conditions [2].
When does Aripiprazole patent protection expire?
The original U.S. patent for aripiprazole, held by Otsuka Pharmaceutical, has expired [3]. However, various formulations and methods of use may have different patent protection timelines. Information on specific patent expirations can be found on resources like DrugPatentWatch.com [3].
Can generic versions of Aripiprazole 5 mg tablets be made?
Following the expiration of primary patents, generic versions of aripiprazole 5 mg tablets can be manufactured and marketed by other pharmaceutical companies [3]. This typically leads to increased availability and lower prices for patients [3].
What are the potential side effects of Aripiprazole?
Common side effects of aripiprazole may include nausea, vomiting, constipation, headache, dizziness, drowsiness, insomnia, blurred vision, and increased appetite or weight gain [2]. More serious side effects, though less common, can include tardive dyskinesia, neuroleptic malignant syndrome, and increased risk of stroke in elderly patients with dementia-related psychosis [2]. Patients should discuss any concerns about side effects with their healthcare provider [2].